VERNDARI
Live / Applied — Non-final action mailed (as of 03 Jun 2026)
Now
Refused for now — an office action was mailed 03 Jun 2026.
A response is due by 03 Dec 2026; with no response the application is abandoned.
What this means for you
Not registered yet, but its 04 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99633973
- Mark type
- Word mark
- Filed
- 04 Feb 2026
- Attorney of record
- Karen K. Won
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Vaccine delivery patches being transdermal patches featuring vaccines; Intradermal patches being adhesive drug delivery patches impregnated with vaccines; Intradermal patches being adhesive drug delivery patches impregnated with pharmaceutical preparations for the treatment of infectious diseases; Microarray patches being adhesive drug delivery devices impregnated with vaccines; Microarray patches being adhesive drug delivery devices impregnated with pharmaceutical preparations for the treatment of infectious diseases; Intradermal patches being adhesive drug delivery patches and microarray patches being adhesive drug delivery devices, all sold filled with therapeutic agents used for the stabilization and delivery of vaccines; Pharmaceutical preparations for the prevention and treatment of infectious diseases; Vaccination kits comprised primarily of therapeutic vaccine preparations and Intradermal patches being adhesive drug delivery patches
- Class 010 — Medical apparatus: Intradermal patches being adhesive drug delivery patches, sold without medication; Microarray patches being adhesive drug delivery devices, sold without medication
- Class 042 — Scientific and technological services: Research and development services in the fields of vaccines, vaccine and drug delivery technologies, intradermal drug and vaccine delivery technologies, and microarray drug and vaccine delivery technologies; Providing medical research information in the fields of vaccines, vaccine and drug delivery technologies, intradermal drug and vaccine delivery technologies, and microarray drug and vaccine delivery technologies
Owner
- Verndari, Inc., Sacramento, CA, US
Prosecution history
- 07 Aug 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 07 Aug 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 03 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Jun 2026 — NON-FINAL ACTION E-MAILED
- 03 Jun 2026 — NON-FINAL ACTION WRITTEN
- 02 Jun 2026 — ASSIGNED TO EXAMINER
- 31 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 04 Feb 2026 — NEW APPLICATION ENTERED